Afya (A2FY34) Stock Overview
Operates as a medical education group in Brazil. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for A2FY34 from our risk checks.
A2FY34 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Afya Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$38.68 |
| 52 Week High | US$57.00 |
| 52 Week Low | US$34.00 |
| Beta | 0.51 |
| 1 Month Change | 10.51% |
| 3 Month Change | -4.54% |
| 1 Year Change | -25.33% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 5.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| A2FY34 | BR Consumer Services | BR Market | |
|---|---|---|---|
| 7D | -3.7% | 1.7% | 3.5% |
| 1Y | -25.3% | 46.0% | 35.9% |
Return vs Industry: A2FY34 underperformed the BR Consumer Services industry which returned 45.5% over the past year.
Return vs Market: A2FY34 underperformed the BR Market which returned 35.5% over the past year.
Price Volatility
| A2FY34 volatility | |
|---|---|
| A2FY34 Average Weekly Movement | 5.8% |
| Consumer Services Industry Average Movement | 8.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in BR Market | 8.8% |
| 10% least volatile stocks in BR Market | 1.7% |
Stable Share Price: A2FY34 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: A2FY34's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Virgilio Deloy Gibbon | www.afya.com.br |
Afya Limited operates as a medical education group in Brazil. The company operates in three segments: Undergraduate, Continuing Education, and Medical Practice Solutions. The Undergraduate segment offers educational services through undergraduate courses related to medical school, health sciences, and other non-health undergraduate programs, including medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, biomedicine, business administration, accounting, law, civil and industrial engineering, and pedagogy.
Afya Limited Fundamentals Summary
| A2FY34 fundamental statistics | |
|---|---|
| Market cap | R$6.93b |
| Earnings (TTM) | R$752.46m |
| Revenue (TTM) | R$3.70b |
Is A2FY34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A2FY34 income statement (TTM) | |
|---|---|
| Revenue | R$3.70b |
| Cost of Revenue | R$1.31b |
| Gross Profit | R$2.38b |
| Other Expenses | R$1.63b |
| Earnings | R$752.46m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.37 |
| Gross Margin | 64.46% |
| Net Profit Margin | 20.35% |
| Debt/Equity Ratio | 42.0% |
How did A2FY34 perform over the long term?
See historical performance and comparisonDividends
Does A2FY34 pay a reliable dividends?
See A2FY34 dividend history and benchmarks| Afya dividend dates | |
|---|---|
| Ex Dividend Date | Mar 24 2026 |
| Dividend Pay Date | Apr 10 2026 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 1 day |
Does A2FY34 pay a reliable dividends?
See A2FY34 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 12:51 |
| End of Day Share Price | 2026/04/09 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Afya Limited is covered by 13 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Flavio Yoshida | BofA Global Research |
| Valeria Parini | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |
| Marcio Osako | Bradesco S.A. Corretora de Títulos e Valores Mobiliários |